Cargando…
Diagnosis and Management of Pembrolizumab-Associated Pericardial Effusion in a Non-small Cell Lung Cancer Patient
The advent of immune checkpoint inhibitors (ICIs) in the field of oncology has improved the outcome response rate for a variety of neoplastic pathologies with improved cellular specificity that lacks the traditional adverse effects associated with chemotherapy. However, ICIs are not without adverse...
Autores principales: | Pollock, James, Castillo, Elquis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183094/ https://www.ncbi.nlm.nih.gov/pubmed/37193471 http://dx.doi.org/10.7759/cureus.37556 |
Ejemplares similares
-
A Case of Congenital Lymphedema Complicated by Chronic Chylous Effusions and Recurrent Pericardial Effusion Requiring Pericardial Window
por: Katabi, Abdulrahman, et al.
Publicado: (2020) -
Hemorrhagic Pericardial Effusion Leading to Cardiac Tamponade: A Rare Initial Presentation of Adenocarcinoma of the Lung
por: Mehmood, Maham A, et al.
Publicado: (2020) -
The Mediport Paradox: Mediastinitis and Pericardial Effusion With a Misplaced Mediport
por: Malik, Bilal, et al.
Publicado: (2022) -
Idiopathic Chylous Pericardial Effusion Due to Lymphatic Malformation of Mediastinum
por: Mishra, Animesh, et al.
Publicado: (2023) -
A Case of Cutibacterium acnes Pericardial Effusion After Coronary Artery Bypass Surgery
por: Moodie, Travis R, et al.
Publicado: (2023)